[Clinical investigation of silymarin in chronic liver diseases (author's transl)].
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002908:Chronic Disease; D005234:Fatty Liver / Q000188:drug therapy; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012838:Silymarin / Q000627:therapeutic use*; D005719:gamma-Globulins / Q000032:analysis
D005419:Flavonoids; D012838:Silymarin; D005719:gamma-Globulins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Essai clinique de la silymarine dans les affections chroniques du foie